Clinical Trials Arena

Nanobiotix’s HNSCC hopeful wins in Phase I oesophageal cancer trial

Nanobiotix's JNJ-1900, which is in Phase III for HNSCC, exhibited an ORR of 69% in oesophageal cancer, potentially ...
Clinical Trials Arena

Long-term benefit of Amgen’s Repatha in reducing MACE shown in Phase III trial

The VESALIUS-CV trial (NCT03872401) has proved its long-term efficacy in these patients after meeting both its primary ...